Volume 12, Number 12—December 2006
Dispatch
Drug Trafficking Routes and Hepatitis B in Injection Drug Users, Manipur, India
Sibnarayan Datta*, Arup Banerjee*, Partha K. Chandra*, Pradip K. Mahapatra†, Shekhar Chakrabarti‡, and Runu Chakravarty*
Table A1
Nucleotide variability in the partial s gene, including the region encoding the major hydrophillic loop, compared with consensus sequences*
| Isolate | 367 | 400 | 414 | 436 | 451 | 454 | 457 | 482 | 484 | 491 | 493 | 494 | 499 | 505 | 511 | 514 | 519 | 520 | 529 | 531 | 544 | 546 | 555 | 562 | 574 | 581 | 586 | 587 | 592 | 598 | 616 | 619 | 629 | 630 | 633 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cn A1 | T | A | T | A | T | T | A | A | T | T | C | A | A | C | A | C | A | A | G | C | C | A | T | A | A | A | T | G | T | C | A | T | G | C | A |
| Cn A2 | – | – | – | G | – | – | – | – | – | – | A | – | – | T | – | A | – | – | – | – | – | – | – | – | – | – | – | – | – | – | G | C | – | – | – |
| Cn D | – | C | – | G | C | – | – | – | – | – | T | T | C | – | – | A | G | – | – | – | A | C | A | C | C | T | C | – | – | – | – | C | – | G | – |
| Cn C1 | C | C | – | G | C | C | – | C | – | A | A | T | T | – | – | A | – | G | – | T | A | C | – | T | – | T | C | – | C | T | – | C | – | – | – |
| Cn C2 | – | C | – | G | C | C | – | C | – | A | A | T | T | – | – | A | – | G | – | T | A | C | – | T | – | T | C | – | – | T | – | – | – | – | G |
| IDU1 | – | – | – | – | – | – | – | – | – | – | A | – | – | T | – | A | – | – | – | – | – | – | – | – | – | T | – | – | – | – | – | C | – | G | – |
| IDU2 | – | – | – | – | – | – | G | – | – | – | A | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| IDU3 | – | – | – | G | C | C | – | – | – | – | A | – | – | – | – | – | – | – | – | – | – | C | – | – | – | T | C | – | – | T | – | – | – | – | – |
| IDU4 | – | – | – | G | C | C | – | C | – | – | A | T | C | – | – | A | – | G | – | T | A | C | – | T | – | T | C | – | C | T | – | – | – | – | G |
| IDU5 | C | – | – | G | C | C | – | C | C | A | A | T | – | – | – | A | – | G | – | T | A | – | – | C | – | T | C | – | C | T | – | C | – | – | – |
| IDU6 | C | – | C | G | C | C | G | C | – | A | A | T | C | – | – | A | – | G | – | T | A | C | – | T | – | T | C | A | C | T | – | C | – | – | G |
| IDU7 | C | – | C | G | C | C | G | C | – | A | A | T | C | – | G | A | – | G | – | T | A | C | – | T | – | T | C | A | C | T | – | C | A | – | G |
| IDU8 | – | C | – | G | C | C | – | C | – | A | A | T | – | – | – | A | – | G | – | T | A | C | – | T | – | T | C | – | – | T | – | – | – | – | G |
| IDU9 | – | C | – | G | C | C | – | C | – | A | A | T | T | – | – | A | – | G | A | T | A | C | – | T | – | T | C | – | – | T | – | – | – | – | G |
| IDU10 | – | C | – | G | C | C | – | C | – | A | A | T | T | – | – | – | – | G | – | T | – | C | – | T | – | T | C | – | – | T | – | – | – | – | G
*Indicated by Cn, followed by genotype/subgenotype. IDU, injection drug user. |
*Indicated by Cn, followed by genotype/subgenotype. IDU, injection drug user.
Page created: October 04, 2011
Page updated: October 04, 2011
Page reviewed: October 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential